Intercept Pharmaceuticals, Inc.: capex

Value{"amount": 1136000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"}
Period2019-01-01 – 2019-12-31
Statuscurrent
EntityIntercept Pharmaceuticals, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001558370-20-001314 · Open the official SEC filing →
Retrieved: 2026-08-19T12:06:47.985899+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001270073/capex/2019-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/9b1982a8-7d1e-4c52-8ad3-4d021d511f9a

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies